BCTXW — Stock Film
STOCK FILMSCENE 1/9BCTXW · $0.0009
Stock Expert AI presents
BCTXW
BriaCell Therapeutics Corp
~3 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
BriaCell Therapeutics Corp. A quick introduction.

It operates in its own corner of the market. Now — the numbers.

$0 market value
Revenue last year:
$0
The loss that same year:
$0
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
The sales picture, year by year.

Red columns mark years that ended in a loss.

$0
2021
$0
2022
$0
2023
$0
2024
$0
2025
In the vault right now:
$0
DEBT: $0
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

THE BRIGHT SIDE

Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.

1
THE RISKS · 1/3
Small sales, big loss

A loss of $26.6M against $0 in annual sales.

2
THE RISKS · 2/3
Trading under $1

The stock sits at $0.0009. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.

3
THE RISKS · 3/3
A wildly swinging price

This stock swings about 2 times as much as the market average. Big rallies — and big drops — can both happen fast.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, BCTXW sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: BCTXW is a high-risk stock — not yet profitable, and its future rides on its product catching on.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film